FDA will consider easing restrictions on peptides as RFK Jr. calls himself a "big fan"

Key Points:

• The FDA will hold a meeting in July to consider easing restrictions on seven peptide injections, popular unapproved therapies promoted by wellness influencers and celebrities, despite limited research on their safety and efficacy.
• Health Secretary Robert F. Kennedy Jr. has advocated for loosening peptide regulations, citing personal use and support from his Make America Healthy Again movement, raising concerns about potential bias in the FDA's review process.
• Critics, including former FDA officials and medical experts, warn that allowing peptides without rigorous clinical testing threatens drug safety standards and could lead to widespread use of potentially unsafe substances.
• The FDA plans to remove these peptides from a restrictive list of unapproved, high-risk drugs, though the agency must still draft formal rules if the advisory panel recommends their availability for compounding pharmacies.
• Peptides like BPC-157 and TB-500, banned in sports for doping, have gained traction in the wellness market and dietary supplements despite safety risks cited by the FDA, including cancer and organ damage, prompting pushback from industry groups and some lawmakers.